Screener
Haemonetics HAE Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Haemonetics’s reported figures.
Based on the most recent quarter.
The source filing: Haemonetics’s 10-Q, filed February 5, 2026. Open the filing →
- Filed
- Feb 5, 2026, 6:05 AM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q4 2025
- Accession
- 0000313143-26-000010
FAQ
- What is Haemonetics's net debt / EBITDA?
- Haemonetics (HAE) reported net debt / EBITDA of 2.4× in Q4 2025.
- How has Haemonetics's net debt / EBITDA changed year-over-year?
- Haemonetics's net debt / EBITDA decreased by 22.6% year-over-year, from 3.1× to 2.4×.
- What is the long-term trend for Haemonetics's net debt / EBITDA?
- Over 4 years (2021 to 2025), Haemonetics's net debt / EBITDA has grown at a -3.7% compound annual growth rate (CAGR), from 3.4× to 2.9×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about Haemonetics's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude